- 全部删除
您的购物车当前为空
Nabumetone (BRL14777) 是一种非甾体抗炎药,是选择性COX-2抑制剂,其活性代谢物 6MNA 可抑制环加氧酶 I 和 II。

Nabumetone (BRL14777) 是一种非甾体抗炎药,是选择性COX-2抑制剂,其活性代谢物 6MNA 可抑制环加氧酶 I 和 II。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 200 mg | ¥ 148 | In stock | |
| 500 mg | ¥ 229 | In stock | |
| 1 g | ¥ 323 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 356 | In stock |
Nabumetone 相关产品
| 产品描述 | Nabumetone (BRL14777)(BRL14777) is a non-steroidal anti-inflammatory drug and its active metabolite 6MNA inhibits the enzymes cyclo-oxygenase I and II. |
| 体外活性 | 在角叉菜胶诱导的大鼠水肿模型和紫外线诱发的豚鼠红疹模型中,Nabumetone具有抗炎活性.在大鼠肉芽肿瘤模型中,Nabumetone在高于最小有效剂量高的浓度,不会产生毒性.在患有佐剂性关节炎的大鼠中,Nabumetone在超过抗炎活性剂量下,对于大鼠的胃有良好的耐受性. |
| 体内活性 | Nabumetone经过广泛的首过代谢,形成主循环活性代谢物(6-MNA),能够抑制COX-2。 |
| 激酶实验 | Cells are harvested, washed, and lysed in NP-40 lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.5% NP-40). Total cell protein is quantified using the Bradford assay and 1-mg/mL protein aliquots are made. Ten microliters of total cell protein is mixed with 290 μL of substrate solution (0.1 mg/mL dithiothreitol [DTT], 0.1 mg/mL albumin, and 1 mM alanine-β-naphthylamide). Fluorometric measurements (340 nm excitation, 400 nm emission) are made after 15 and 30 min. The slope of the line between the 15- and 30-min measurements is used to represent aminopeptidase activity. Total cell protein is preincubated with bestatin, amastatin, puromycin, EDTA, and/or ZnCl2 for 20 min before the fluorometric aminopeptidase assay. |
| 别名 | 萘丁美酮, BRL14777 |
| 分子量 | 228.29 |
| 分子式 | C15H16O2 |
| CAS No. | 42924-53-8 |
| Smiles | C(CC(C)=O)C1=CC2=C(C=C(OC)C=C2)C=C1 |
| 密度 | 1.0657 g/cm3 (Estimated) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 55 mg/mL (240.92 mM), Sonication is recommended. Ethanol: 24 mg/mL (105.13 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容